dc.contributor.author | Rueda Espinel, Santiago | |
dc.coverage.spatial | Bucaramanga (Santander, Colombia) | spa |
dc.coverage.temporal | 2021 | spa |
dc.date.accessioned | 2023-06-28T23:11:34Z | |
dc.date.available | 2023-06-28T23:11:34Z | |
dc.date.issued | 2021-11 | |
dc.identifier.issn | ISSN 2344-7079 | spa |
dc.identifier.uri | http://hdl.handle.net/20.500.12749/20369 | |
dc.description.abstract | En éste documento se detallan las indicaciones básicas a seguir para la presentación de trabajos de investigación al XII Encuentro de Semilleros de Investigación “El Intercambio del Conocimiento: Base para el Desarrollo” | spa |
dc.format.mimetype | application/pdf | spa |
dc.language.iso | spa | spa |
dc.relation.ispartofseries | Generación Creativa : Encuentro de Semilleros de Investigación UNAB | spa |
dc.relation.uri | http://hdl.handle.net/20.500.12749/20335 | spa |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/2.5/co/ | * |
dc.source | Rueda, S. (2021). Factores asociados al éxito del manejo médico con misoprostol en el aborto espontáneo: una cohorte prospectiva. Recuperado de: http://hdl.handle.net/20.500.12749/20369. | spa |
dc.title | Factores asociados al éxito del manejo médico con misoprostol en el aborto espontáneo: una cohorte prospectiva | spa |
dc.type | Conference | eng |
dc.title.translated | Factors associated with the success of medical management with misoprostol in spontaneous abortion: a prospective cohort | spa |
dc.publisher.grantor | Universidad Autónoma de Bucaramanga UNAB | spa |
dc.rights.local | Abierto (Texto Completo) | spa |
dc.publisher.faculty | Facultad Ciencias de la Salud | spa |
dc.type.driver | info:eu-repo/semantics/conferenceProceedings | spa |
dc.type.local | Memoria de eventos | spa |
dc.type.coar | http://purl.org/coar/resource_type/c_f744 | |
dc.subject.keywords | Gynecology | spa |
dc.subject.keywords | Obstetrics | spa |
dc.subject.keywords | Abortion | spa |
dc.subject.keywords | Investigation | spa |
dc.subject.keywords | Misoprostol | spa |
dc.subject.keywords | Maternal mortality | spa |
dc.subject.keywords | Pregnancy | spa |
dc.subject.keywords | Women | spa |
dc.identifier.instname | instname:Universidad Autónoma de Bucaramanga - UNAB | spa |
dc.identifier.reponame | reponame:Repositorio Institucional UNAB | spa |
dc.type.hasversion | info:eu-repo/semantics/acceptedVersion | spa |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
dc.relation.references | [1] Peña García MJ. Guía de Práctica Clínica (GPC) para el manejo médico del aborto en el Hospital Local del Norte - E.S.E ISABU. 2018; | spa |
dc.relation.references | [2] Organización Mundial de la Salud. Mortalidad materna. 2018;Nota descriptiva No. 348. | spa |
dc.relation.references | [3] Sur SD, Raine-Fenning NJ. The management of miscarriage. Best Pract Res Clin Obstet Gynaecol. Elsevier Ltd. 2009;23(4):479–91. | spa |
dc.relation.references | [4] Blum J, Winikoff B, Gemzell-Danielsson K, Ho PC, Schiavon R, Weeks A. Treatment of incomplete abortion and miscarriage with misoprostol. Int J Gynecol Obstet. 2007;99:186–9. | spa |
dc.relation.references | [5] Creinin MD, Barnhart K, Zhang J, Gilles JM, Westhoff C, Huang X. Factors Related to Successful Misoprostol Treatment for Early Pregnancy Failure. Obstet Gynecol. 2006;107(4):901–7. | spa |
dc.relation.references | [6] Barceló F, De Paco C, López-Espín JJ, Silva Y, Abad L, Parrilla JJ. The management of missed miscarriage in an outpatient setting: 800 versus 600 μg of vaginal misoprostol. Aust New Zeal J Obstet Gynaecol. 2012;52(1):39–43. | spa |
dc.relation.references | [7] Committee on Practice Bulletins—Gynecology. Early Pregnancy Loss. Am Coll Obstet Gynecol [Internet]. 2015; number 150. Available from: https://www.acog.org/Clinical-Guidance-and-Publications/Practice- Bulletins/Committee-on-Practice-Bulletins-Gynecology/Early-Pregnancy-Loss | spa |
dc.relation.references | [8] Hasan R, Baird DD, Herring AH, Olshan AF, Jonsson Funk ML, Hartmann KE. Association between first- trimester vaginal bleeding and miscarriage. Obstet Gynecol. 2009;114(4):860–7. | spa |
dc.relation.references | [9] Faúndes A, Fiala C, Tang OS, Velasco A. Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy. Int J Gynecol Obstet. 2007;99:172–7. | spa |
dc.relation.references | [10] Bagratee JS, Khullar V, Regan L, Moodley J, Kagoro H. A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Hum Reprod. 2004;19(2):266–71. | spa |
dc.relation.references | [11] INVIMA. Mifepristona [Internet]. Expediente 20104433. 2016. Available from: http://consultaregistro.invima.gov.co:8082/Consultas/consultas/consreg_encabcum.jsp | spa |
dc.relation.references | [12] von Hertzen H, Piaggio G, Huong NTM, Arustamyan K, Cabezas E, Gomez M, et al. Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial. Lancet. 2007;369(9577):1938–46. | spa |
dc.relation.references | [13] Tang OS, Ho PC. The pharmacokinetics and different regimens of misoprostol in early first-trimester medical abortion. Contraception. 2006;74(1):26–30. | spa |
dc.relation.references | [14] Committee on Practice Bulletins—Gynecology and the Society of Family Planning. Medical management of first-trimester abortion. Am Coll Obstet Gynecol. 2014;89(3):148–161. | spa |
dc.relation.references | [15] Tang J, Kapp N, Dragoman M, De Souza JP. WHO recommendations for misoprostol use for obstetric and gynecologic indications. Int J Gynecol Obstet [Internet]. 2013;121(2):186–9. Available from: http://dx.doi.org/10.1016/j.ijgo.2012.12.009 | spa |
dc.relation.references | [16] Jp N, Gml G, Hickey M, Jc V, Dou L. Medical treatments for incomplete miscarriage (Review). Cochrane Libr. 2013;(3). | spa |
dc.relation.references | [17] Gómez-Sánchez P. Manual FLASOG uso Misoprostol en Ginecoobstetricia. 2013. | spa |
dc.relation.references | [18] INVIMA. Acta 20, Radicado 7023192. Minist Salud y Protección Soc. 2007. | spa |
dc.relation.references | [19] Corte Constitucional. Sentencia C-355/06 [Internet]. República de Colombia. 2006. Available from: http://www.corteconstitucional.gov.co/relatoria/2006/c-355-06.htm | spa |
dc.relation.references | [20] INVIMA. Decreto No. 4444. 2005. | spa |
dc.relation.references | [21] Colombia Ministerio de la Protección Social. Resolución 4905 [Internet]. 2006. Available from: https://www.minsalud.gov.co/Normatividad_Nuevo/Resolución 4905 de 2006.PDF | spa |
dc.relation.references | [22] Blanchard K, Shochet T, Coyaji K, Nguyen Thi NN, Winikoff B. Misoprostol alone for early abortion: An evaluation of seven potential regimens. Contraception. 2005;72(2):91–7. | spa |
dc.relation.references | [23] Gemzell-Danielsson K, Bygdeman M, Aronsson A. Studies on uterine contractility following mifepristone and various routes of misoprostol. Contraception. 2006;74(1):31–5. | spa |
dc.relation.references | [24] Gemzell-Danielsson, L Marions, A Rodriguez, BW Spur, PYK Wong MB. Comparison Between Oral and Vaginal Administration of Misoprostol on Uterine Contractility. Am Coll Obstet Gynecol Elsevier. 1999;93(2):275–80. | spa |
dc.relation.references | [25] Granstrom G, Granstrom M, Anderson M. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone mifepristone and an exogenous prostaglandin given. Lancet. 1991;338:1233–6. | spa |
dc.relation.references | [26] Odeh M, Tendler R, Kais M, Maximovsky O, Ophir E, Bornstein J. Early pregnancy failure: Factors affecting successful medical treatment. Isr Med Assoc J. 2010;12(6):325–8. | spa |
dc.relation.references | [27] Fiala C, Cameron S, Bombas T, Parachini M, Agostini A, Lertxundi R, et al. Outcome of first trimester medical termination of pregnancy: definitions and management. Eur J Contracept Reprod Heal Care [Internet]. 2018;23(6):451–7. Available from: https://doi.org/10.1080/13625187.2018.1535058 | spa |
dc.relation.references | [28] Chung T, Leung P, Cheung L, Haines C, Chang A. A medical approach to management of spontaneous abortion using misoprostol. Acta Obstet Gynecol Scand. 1997;76:248–51. | spa |
dc.relation.references | [29] Cheung LP, Haines CJ, Chang AMZ. Spontaneous abortion: a randomized, controlled trial comparing surgical evacuation with conservative management using misoprostol. Fertil Steril. 1999;71(6):1054–9. | spa |
dc.relation.references | [30] Creinin MD, Chen MJ. Medical abortion reporting of efficacy: the MARE guidelines. Contraception [Internet]. 2016;94(2):97–103. Available from: http://dx.doi.org/10.1016/j.contraception.2016.04.013 | spa |
dc.relation.references | [31] Morris JL, Winikoff B, Dabash R, Weeks A, Faundes A, Gemzell-Danielsson K, et al. FIGO’s updated recommendations for misoprostol used alone in gynecology and obstetrics. Int J Gynecol Obstet. 2017;138(3):363–6. | spa |
dc.relation.references | [32] Berghella V, Airoldi J, O’Neill A, Einhorn K, Hoffman M. Misoprostol for second trimester pregnancy termination in women with prior caesarean: A systematic review. BJOG An Int J Obstet Gynaecol. 2009;116(9):1151–7. | spa |
dc.relation.references | [33] Goyal V. Uterine rupture in second-trimester misoprostol-induced abortion after cesarean delivery: A systematic review. Am Coll Obstet Gynecol. 2009;113(5):1117–23. | spa |
dc.relation.references | [34] Chen BA, Reeves MF, Creinin MD, Gilles JM, Barnhart K, Westhoff C, et al. Misoprostol for treatment of early pregnancy failure in women with previous uterine surgery. Am J Obstet Gynecol. 2008;198(6):626.e1-626.e5. | spa |
dc.relation.references | [35] Memtsa M, Jauniaux E, Gulbis B, Nyrhinen NC, Jurkovic D. Maternal serum markers in predicting successful outcome in expectant management of missed miscarriage. Reprod Biomed Online, Elsevier [Internet]. 2017;34(1):98–103. Available from: http://dx.doi.org/10.1016/j.rbmo.2016.09.004 | spa |
dc.contributor.cvlac | Rueda Espinel, Santiago [0000037531] | spa |
dc.contributor.orcid | Rueda Espinel, Santiago [0000-0003-2156-166X] | spa |
dc.subject.lemb | Ginecología | spa |
dc.subject.lemb | Obstetricia | spa |
dc.subject.lemb | Aborto | spa |
dc.subject.lemb | Investigación | spa |
dc.identifier.repourl | repourl:https://repository.unab.edu.co | spa |
dc.description.abstractenglish | In this paper, we describe the formatting guidelines for the XII Encuentro de Semilleros de Investigación “El Intercambio del Conocimiento: Base para el Desarrollo". The abstract most be written in english. | spa |
dc.subject.proposal | Misoprostol | spa |
dc.subject.proposal | Mortalidad materna | spa |
dc.subject.proposal | Embarazo | spa |
dc.subject.proposal | Mujeres | spa |
dc.type.redcol | http://purl.org/redcol/resource_type/EC_AC | |
dc.rights.creativecommons | Atribución-NoComercial-SinDerivadas 2.5 Colombia | * |
dc.publisher.deparment | Sistema de Investigación SIUNAB | spa |
dc.contributor.researchgroup | Semilleros de Investigación UNAB | spa |
dc.type.coarversion | http://purl.org/coar/version/c_ab4af688f83e57aa | spa |
dc.coverage.campus | UNAB Campus Bucaramanga | spa |
dc.description.learningmodality | Modalidad Presencial | spa |